Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Ulcerative Colitis”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07755241
What this trial is testing

AC-101 Tablets in Patients With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Accro Bioscience (Suzhou) Limited 153
Large-scale testing (Phase 3)Ended earlyNCT04985968
What this trial is testing

The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
InDex Pharmaceuticals 171
Testing effectiveness (Phase 2)Study completedNCT01461317
What this trial is testing

Study to Evaluate the Long-term Safety of Etrolizumab in Participants With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Genentech, Inc. 121
Not applicableStudy completedNCT02914717
What this trial is testing

The Belgian SMART Study Evaluating the Use of Golimumab for Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Universitaire Ziekenhuizen KU Leuven 100
Not applicableLooking for participantsNCT06962020
What this trial is testing

Selection and Efficacy-Influencing Factors of First-Line Biologic Agents in Moderate-to-Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Xijing Hospital of Digestive Diseases 400
Large-scale testing (Phase 3)Study completedNCT01585155
What this trial is testing

Clinical Study of TA-650 in Pediatric Patients With Ulcerative Colitis

Who this might be right for
Pediatric Ulcerative Colitis
Tanabe Pharma Corporation 21
Large-scale testing (Phase 3)Study completedNCT03482635
What this trial is testing

BI655130 (SPESOLIMAB) Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Boehringer Ingelheim 98
Testing effectiveness (Phase 2)Active Not RecruitingNCT05242484
What this trial is testing

Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 577
Large-scale testing (Phase 3)Study completedNCT00347048
What this trial is testing

Tacrolimus (FK506) Study in Moderate to Severe Refractory Ulcerative Colitis Patients

Who this might be right for
Ulcerative Colitis
Astellas Pharma Inc 62
Large-scale testing (Phase 3)Study completedNCT02136069
What this trial is testing

A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) Inhibitors

Who this might be right for
Ulcerative Colitis
Hoffmann-La Roche 397
Testing effectiveness (Phase 2)Study completedNCT03934216
What this trial is testing

Safety and Efficacy of Deucravacitinib in Participants With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Bristol-Myers Squibb 131
Testing effectiveness (Phase 2)Study completedNCT04504383
What this trial is testing

PN-943 in Adults With Moderate to Severe Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis Chronic ModerateUlcerative Colitis Chronic Severe
Protagonist Therapeutics, Inc. 169
Large-scale testing (Phase 3)Ended earlyNCT02118584
What this trial is testing

Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies

Who this might be right for
Ulcerative Colitis
Hoffmann-La Roche 1,822
Early research (Phase 1)Not Yet RecruitingNCT07768254
What this trial is testing

Evaluate the Safety, Tolerability, PK and Preliminary Efficacy of HX15001 Combined With Etrasimod in Moderate-severe Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Helixon Biotechnology (Suzhou) Co., Ltd 32
Testing effectiveness (Phase 2)Ended earlyNCT06137183
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
Genentech, Inc. 79
Early research (Phase 1)UnknownNCT01697670
What this trial is testing

Photodynamic Therapy for Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
University of Zurich 7
Not applicableStudy completedNCT02229344
What this trial is testing

Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Korea

Who this might be right for
Colitis, Ulcerative
Janssen Korea, Ltd., Korea 368
Large-scale testing (Phase 3)Study completedNCT02819635
What this trial is testing

Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis (UC)
AbbVie 1,302
Large-scale testing (Phase 3)Study completedNCT03290781
What this trial is testing

An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Shire 366
Post-approval studies (Phase 4)Ended earlyNCT03591770
What this trial is testing

Shingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on Tofacitinib

Who this might be right for
Inflammatory Bowel Diseases
Boston Medical Center 15
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation